doi: 10.1161/hy0202.103413
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;39:353.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
The Y Chromosome Effect on Blood Pressure in Two European Populations
From the British Heart Foundation Blood Pressure Group (F.J.C., M.T., S.P., M.N.U., G.C.I., N.H.A., A.M., J.M.C.C., G.C.M.W., A.F.D.), Department of Medicine and Therapeutics and Department of General Practice, University of Glasgow, United Kingdom; and Department of Internal Medicine, Diabetology and Nephrology (B.L., E.Z.-S., W.G.), Silesian School of Medicine, Zabrze, Poland.
Correspondence to Professor Anna F. Dominiczak, Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary, Glasgow G11 6NT, United Kingdom. E-mail ad7e{at}clinmed.gla.ac.uk
Higher blood pressure (BP) in males compared with females is well documented and is thought to be influenced in part by the Y chromosome. To examine whether there is an association between BP and a polymorphic HindIII biallelic marker in the nonrecombining region of the Y chromosome, we genotyped 155 males from a Polish study group and 762 males from a Scottish study group. We also tested for possible interaction between the Y chromosome and a mutation in the steroidogenic factor binding site of the aldosterone synthase gene by genotyping the same group from Scotland. There was no significant difference in age or body mass index between 2 Y chromosome genotypes in both study groups. Men with the HindIII(+) genotype had significantly higher systolic and diastolic pressures than those with the HindIII(-) genotype in both the Polish and Scottish studies. This difference between the genotypes was 5.27 mm Hg (P=0.0014) and 3.14 mm Hg (P=0.0005) for adjusted systolic BP and 2.6 mm Hg (P=0.0045) and 1.44 mm Hg (P=0.0084) for adjusted diastolic BP in the Polish and the Scottish studied, respectively. On binary logistic regression analysis, males with the HindIII(+)/TT SF1 genotype combination had an odds ratio for elevated BP of 3.92 (CI 1.21 to 12.68, P=0.023). Our results indicate that the Y chromosome harbors a locus or loci that contribute to BP variation in hypertensive and normotensive men. The polymorphism in the aldosterone synthase gene may interact with the Y chromosome to increase the odds of an individual’s developing higher BP.
Key Words: hypertension, essential • genetics • gender • genes • blood pressure • aldosterone
This article has been cited by other articles:
 |
|
 |
|
  M. E. Turner, J. Farkas, J. Dunmire, D. Ely, and A. Milsted Which Sry Locus Is the Hypertensive Y Chromosome Locus? Hypertension, February 1, 2009; 53(2): 430 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Oriel, C. D. Wiley, M. J. Dewey, and P. B. Vrana Adaptive genetic variation, stress and glucose regulation Dis. Model. Mech., November 1, 2008; 1(4-5): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Russo, A. Siani, M. A. Miller, S. Karanam, T. Esposito, F. Gianfrancesco, G. Barba, F. Lauria, P. Strazzullo, and F. P. Cappuccio Genetic Variants of Y Chromosome Are Associated With a Protective Lipid Profile in Black Men Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1569 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hart, A. McConnachie, M. Upton, and G. Watt Risk factors in the Midspan family study by social class in childhood and adulthood Int. J. Epidemiol., June 1, 2008; 37(3): 604 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Prows, A. P. Hafertepen, W. J. Gibbons Jr., A. V. Winterberg, and T. G. Nick A genetic mouse model to investigate hyperoxic acute lung injury survival Physiol Genomics, August 20, 2007; 30(3): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pilote, K. Dasgupta, V. Guru, K. H. Humphries, J. McGrath, C. Norris, D. Rabi, J. Tremblay, A. Alamian, T. Barnett, et al. A comprehensive view of sex-specific issues related to cardiovascular disease Can. Med. Assoc. J., March 13, 2007; 176(6): S1 - S44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Pratt Central Role for ENaC in Development of Hypertension J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3154 - 3159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Shankar, G. J. Eckert, C. Saha, W. Tu, and J. H. Pratt The Change in Blood Pressure during Pubertal Growth J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 163 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tomaszewski, F. J. Charchar, B. Lacka, U. Pesonen, W. Y.S. Wang, E. Zukowska-Szczechowska, W. Grzeszczak, and A. F. Dominiczak Epistatic Interaction Between {beta}2-Adrenergic Receptor and Neuropeptide Y Genes Influences LDL-Cholesterol in Hypertension Hypertension, November 1, 2004; 44(5): 689 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Charchar, M. Tomaszewski, B. Lacka, J. Zakrzewski, E. Zukowska-Szczechowska, W. Grzeszczak, and A. F. Dominiczak Association of the Human Y Chromosome with Cholesterol Levels in the General Population Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 308 - 312. [Abstract] [Full Text]
|
|
|
|
|
|
J. M.C. Connell, R. Fraser, S. MacKenzie, and E. Davies Is Altered Adrenal Steroid Biosynthesis a Key Intermediate Phenotype in Hypertension? Hypertension, May 1, 2003; 41(5): 993 - 999. [Abstract] [Full Text] [PDF]
|
|